545 CONCORD AVENUE, CAMBRIDGE, MA
Market cap: $20.3M (11/26/2024)
Price: $2.36
Other Events
Announces 1-for-11 Reverse Stock Split
Presents Positive New Phase 2a Data on Vanoglipel (DA-1241) in Patients with Presumed MASH at the AASLD The Liver Meeting® 2025
Investor Presentation
Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Extends 48 mg MAD Portion of Its Phase 1 Clinical Trial of DA-1726 for the Treatment of Obesity to 8 Weeks and Announces Fifth Weekly Dose in First Patient
Q3
Q2
Q1
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(3)
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Post-Effective Amendment to Registration Statement
Correspondence
Submission Upload